Xiujie Sheng

673 total citations
24 papers, 454 citations indexed

About

Xiujie Sheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiujie Sheng has authored 24 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xiujie Sheng's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiujie Sheng is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiujie Sheng collaborates with scholars based in China, United States and Hong Kong. Xiujie Sheng's co-authors include Shuo Chen, Yang Zhao, Zhi‐Hong Zong, Juan Liu, Yuanli He, Shaohua Du, Bohong Cen, Yuping Du, Lei Yang and Yanqing Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Cell Death and Disease.

In The Last Decade

Xiujie Sheng

20 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiujie Sheng China 10 292 227 61 56 48 24 454
Emilie Marion Canuto Italy 12 471 1.6× 394 1.7× 88 1.4× 31 0.6× 40 0.8× 16 633
Huaijun Zhou China 14 291 1.0× 242 1.1× 88 1.4× 87 1.6× 62 1.3× 38 523
Xiangyang Zeng China 8 225 0.8× 174 0.8× 92 1.5× 101 1.8× 101 2.1× 17 492
Canhui Jin China 13 334 1.1× 262 1.2× 113 1.9× 21 0.4× 36 0.8× 16 494
Minyue Tang China 11 302 1.0× 234 1.0× 27 0.4× 48 0.9× 74 1.5× 20 470
Monica Dandapani United States 7 200 0.7× 154 0.7× 97 1.6× 29 0.5× 22 0.5× 14 396
Mulan Ren China 13 187 0.6× 136 0.6× 127 2.1× 109 1.9× 59 1.2× 52 556
Katie A. Ashton Australia 12 224 0.8× 120 0.5× 170 2.8× 36 0.6× 73 1.5× 23 457
Weiya Z. Wysham United States 12 222 0.8× 137 0.6× 133 2.2× 78 1.4× 19 0.4× 23 467
Shang‐Lang Huang Taiwan 13 195 0.7× 111 0.5× 111 1.8× 55 1.0× 65 1.4× 23 445

Countries citing papers authored by Xiujie Sheng

Since Specialization
Citations

This map shows the geographic impact of Xiujie Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujie Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujie Sheng more than expected).

Fields of papers citing papers by Xiujie Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiujie Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujie Sheng. The network helps show where Xiujie Sheng may publish in the future.

Co-authorship network of co-authors of Xiujie Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiujie Sheng. A scholar is included among the top collaborators of Xiujie Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiujie Sheng. Xiujie Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yanfang, et al.. (2025). Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma. Scientific Reports. 15(1). 2210–2210. 1 indexed citations
2.
Sheng, Xiujie, et al.. (2025). N-acetyltransferase 10 Promotes Cervical Cancer Progression Via N4-acetylation of SLC7A5 mRNA. Frontiers in Bioscience-Landmark. 30(2). 26756–26756.
4.
Li, Jianqi, et al.. (2024). Current status of high-risk HPV infection and correlation with multiple infections in cervical lesions in Western Guangzhou. Frontiers in Medicine. 11. 1252073–1252073. 3 indexed citations
5.
Zhao, Yang, et al.. (2024). Role of HPV E7/miR-143-3p/SH2D3A pathway in regulating the occurrence and development of cervical cancer. Journal of Gynecologic Oncology. 36(2). e34–e34.
6.
Li, Jianqi, Xiaojie Li, & Xiujie Sheng. (2023). Four-year analysis of high-risk human papillomavirus infection among women in rural areas of Nyingchi City, Tibet. Frontiers in Public Health. 11. 1251440–1251440. 2 indexed citations
7.
Li, Qianhui, et al.. (2023). SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation. Cell Death Discovery. 9(1). 192–192. 11 indexed citations
8.
Wang, Liya, Xiujie Sheng, Qiming Wang, et al.. (2020). <p>Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis</p>. Cancer Management and Research. Volume 12. 10841–10848. 7 indexed citations
9.
Zhang, Yuping, Yonger Chen, Baixue Li, et al.. (2020). The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis. Biomedicine & Pharmacotherapy. 129. 110408–110408. 47 indexed citations
11.
Zong, Zhi‐Hong, et al.. (2019). CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy. 114. 108787–108787. 44 indexed citations
12.
Liu, Yao, Shuo Chen, Zhi‐Hong Zong, et al.. (2019). circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Biomedicine & Pharmacotherapy. 114. 108832–108832. 60 indexed citations
13.
Chen, Ruichao, Wenya Liu, Hui Chen, et al.. (2018). Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma. Cell Death and Disease. 10(1). 4–4. 36 indexed citations
14.
Huang, Hongbiao, Ni Liu, Yuning Liao, et al.. (2017). Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition. Journal of Experimental & Clinical Cancer Research. 36(1). 79–79. 20 indexed citations
15.
Du, Shaohua, et al.. (2015). MicroRNA-29b Inhibits Endometrial Fibrosis by Regulating the Sp1-TGF-β1/Smad-CTGF Axis in a Rat Model. Reproductive Sciences. 23(3). 386–394. 84 indexed citations
16.
Sheng, Xiujie, Zhen Li, Zhihui Wang, et al.. (2014). MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET. Oncology Letters. 8(2). 891–897. 27 indexed citations
17.
Sheng, Xiujie, Lei Yang, Zhiyi Chen, et al.. (2014). Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncology Reports. 32(1). 277–285. 71 indexed citations
18.
Li, Cuilan, Dunjin Chen, Xiujie Sheng, et al.. (2012). [The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy].. PubMed. 47(10). 764–8. 7 indexed citations
19.
Sheng, Xiujie. (2006). Expression of p27 Protein in Endometrial Carcinoma.
20.
Guo, Yi, et al.. (2004). Evaluation on quality of life for gynecologic cancer patients. Chinese Journal of Cancer Research. 16(4). 292–296. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026